Drug intelligence / Profile preview

Relinqing Tablets

Development stage
Unknown
Lead developer
Zhejiang Kangde Pharmaceutical Group
Administration
Oral
01

Overview

Relinqing Tablets is a Traditional Chinese Medicine (TCM) formulation developed and marketed by Zhejiang Kangde Pharmaceutical. It is prepared from the medicinal plant *Polygonum capitatum* Buch-Ham. ex D., a traditional Miao-nationality herb. The drug is approved by the Chinese Food and Drug Administration (NMPA) for the treatment of urinary system diseases, including urinary tract infections, pyelonephritis, cystitis, and urinary calculi. In TCM terms, it is characterized by its ability to clear heat, reduce fire, and promote diuresis, thereby addressing symptoms like frequent, urgent, and painful urination. The Relinqing series, which also includes granules and capsules, is recognized as a leading Chinese patent medicine for urinary tract conditions.

Brand names
Relinqing
Other names
Relinqing Pian
02

Targets

SLC22A8 (Organic anion transporter 3)OAT1 (Organic anion transporter 1)

Beyond the preview

Go deeper on Relinqing Tablets.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Relinqing Tablets.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call